The diversity of available treatments necessitates a clear understanding of the Osteoporosis Drugs Market Segment, which is primarily divided into antiresorptive agents and bone-forming (anabolic) agents. This group discussion delves into the specific roles of each segment within a patient's journey. Antiresorptive drugs, like bisphosphonates and RANKL inhibitors, remain the "first line" of...